Seeking Alpha

Halozyme Therapeutics (HALO) hooks up with Pfizer (PFE) to develop and market products combining...

Halozyme Therapeutics (HALO) hooks up with Pfizer (PFE) to develop and market products combining Halozyme's rHuPH20 with Pfizer's proprietary biologics. Halozyme receives an upfront payment of $8M, and future payments of up to $507M will depend on Pfizer's reaching of certain targets. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector